BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 19125088)

  • 21. [Drug therapy of malignant lymphoma].
    Ogawa M; Inagaki J
    Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
    [No Abstract]   [Full Text] [Related]  

  • 22. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The practice of chemotherapy with the DeVita protocol].
    Gassmann W; Schmitz N; Löffler H
    Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory Hodgkin lymphoma.
    von Tresckow B; Engert A
    Curr Opin Oncol; 2013 Sep; 25(5):463-9. PubMed ID: 23942291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 28. Tracheoesophageal fistula in the patient with lymphoma: case report and review of the literature.
    Perry RR; Rosenberg RK; Pass HI
    Surgery; 1989 Jun; 105(6):770-7. PubMed ID: 2471284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Erythema nodosum association with malignant lymphoma].
    Pileckyte M; Griniūte R
    Medicina (Kaunas); 2003; 39(5):438-42. PubMed ID: 12794364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome.
    Pastorczak A; Szczepanski T; Mlynarski W;
    Eur J Med Genet; 2016 Mar; 59(3):126-32. PubMed ID: 26826318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nijmegen breakage syndrome: case report and review of literature.
    Hasbaoui BE; Elyajouri A; Abilkassem R; Agadr A
    Pan Afr Med J; 2020; 35():85. PubMed ID: 32537088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nijmegen breakage syndrome and chronic polyarthritis.
    Pasic S; Cupic M; Jovanovic T; Djukic S; Kavaric M; Lazarevic I
    Ital J Pediatr; 2013 Sep; 39():59. PubMed ID: 24044622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of premature ovarian insufficiency in Nijmegen breakage syndrome patient and review of literature. From gene mutation to clinical management.
    Szeliga A; Zysnarska A; Szklarska Z; Truszkowska E; Podfigurna A; Czyzyk A; Genazzani AR; Chrzanowska K; Meczekalski B
    Gynecol Endocrinol; 2019 Nov; 35(11):999-1002. PubMed ID: 31187634
    [No Abstract]   [Full Text] [Related]  

  • 34. Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.
    Pastorczak A; Attarbaschi A; Bomken S; Borkhardt A; van der Werff Ten Bosch J; Elitzur S; Gennery AR; Hlavackova E; Kerekes A; Křenová Z; Mlynarski W; Szczepanski T; Wassenberg T; Loeffen J
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome.
    Jovanovic A; Minic P; Scekic-Guc M; Djuricic S; Cirkovic S; Weemaes C; Pasic S
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):49-52. PubMed ID: 19125088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
    Molnár Z; Fleischmann T
    Orv Hetil; 1992 Jun; 133(25):1561-3. PubMed ID: 1383902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
    Hermann R; Greminger P; Dommann-Scherrer C; Krestin GP; Stahel R
    Schweiz Med Wochenschr; 1994 Sep; 124(38):1666-71. PubMed ID: 7524146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Diehl V; Fuchs M;
    Transfus Apher Sci; 2007 Aug; 37(1):37-41. PubMed ID: 17714996
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.